Av sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - publicerad 10 maj 2021 Forskare har funnit en variant av botox som är både miljövänlig och giftig för malariamyggor. Bild: Mostphotos Hallå där Pål Stenmark, professor i strukturell biokemi på EMV, som tilldelas Lindblomska belöningen 2021 från Kungliga vetenskapsakademin för sin upptäckt av ett nytt botox-gift mot malariamyggor!

https://www.medicin.lu.se/artikel/botox-mot-myggor - 2025-02-21

Av anna [dot] hellgren [at] med [dot] lu [dot] se (Anna Hellgren) - publicerad 11 maj 2021 Bundy Academy’s stora pris 2021 om 3 miljoner kronor ut delas ut till Alexandru Schiopu, docent i kardiologi vid Lunds universitet och överläkare i internmedicin vid Skånes universitetssjukhus i Lund. Foto: Tove Smeds. Bundy Academy’s stora pris om 3 miljoner kronor ut delas ut till Alexandru Schiopu, docent

https://www.medicin.lu.se/artikel/2021-ars-pristagare-av-bundy-academys-stora-pris-i-kardiologi - 2025-02-21

Publicerad 11 maj 2021 Foto: Adam Linder och Ulrika Knutsson Som vi tidigare rapporterat tilldelades Sepsisfonden Global Sepsis Award 2020. I dag är det dags för priset att delas ut under en digital livesänd prisceremoni till Sepsisfondens grundare Adam Linder, docent och infektionsforskare vid Institutionen för kliniska vetenskaper i Lund och överläkare vid Skånes universitetssjukhus och Ulrika K

https://www.medicin.lu.se/artikel/sepsisfonden-tilldelas-prestigefyllda-global-sepsis-awards-2020-prisceremoni - 2025-02-21

Av tove [dot] gilvad [at] med [dot] lu [dot] se (Tove Gilvad) - publicerad 18 maj 2021 Charlotte Ling. Foto: Sara Liedholm. Charlotte Ling, professor i epigenetik vid Lunds universitet, får tio miljoner danska kronor från Novo Nordisk fonden för ett forskningsprojekt inom epigenetik och typ 2-diabetes. Hon är en av totalt 38 forskargruppsledare som får anslag genom Novo Nordisk Foundation Research

https://www.medicin.lu.se/artikel/charlotte-ling-far-miljonanslag-fran-novo-nordisk-fonden - 2025-02-21

Published 11 December 2019 The European Research Council today announced the winners of its latest Consolidator Grant competition: 301 top scientists and scholars across Europe. Funding for these researchers, part of the Horizon 2020 research and innovation programme, is worth in total EUR 600 million. Filipe Pereira at Lund University in Sweden is one of the 89 selected researchers, and will be a

https://www.medicine.lu.se/article/prestigious-erc-grant-innovative-immunotherapy-research - 2025-02-21

Published 13 December 2019 Zaal Kokaia, Professor within the Department of Clinical Sciences and Director of Lund Stem Cell Center, has been awarded Georgia’s most prestigious scientific prize - the National Prize in Science. The award comes as a result of his outstanding contribution to world class scientific research and was presented to Prof. Kokaia at a ceremony in the Presidential Palace, Tbi

https://www.medicine.lu.se/article/prestigious-scientific-prize-awarded-director-lund-stem-cell-center - 2025-02-21

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 18 December 2019 Prof. Åsa Petersén, Dep. of Experimental Medical Science, Astri Arnesen, President of The European Huntington Assocation and Patrick Weydt, the European Huntington Disease Network at the Nordic Huntington Disease Research Meeting in Lund. A few weeks ago The Huntington Disease Center in Lund, Swede

https://www.medicine.lu.se/article/european-huntington-heights-met-lund-summit - 2025-02-21

Published 9 January 2020 Anna Häger Glenngård and Sixten Borg. (Photo: Louise Larsson) The risk of experiencing financial difficulties due to medical care costs is relatively small in Sweden. This is revealed in a recent report from the World Health Organization, where researchers from Lund University have investigated the extent to which Swedish households are financially affected by using the he

https://www.medicine.lu.se/article/who-report-healthcare-sweden-among-most-affordable-europe - 2025-02-21

Published 9 January 2020 Merab Kokaia and My Andersson (Photo: Tove Smeds) Researchers at Lund University in Sweden have used a neuropeptide to successfully reduce seizure-like activity in tissue from patients with drug-resistant epilepsy. One challenge facing researchers who study brain diseases is that for understandable reasons it is difficult to obtain human brain tissue for experiments. For t

https://www.medicine.lu.se/article/peptide-reduced-epileptic-seizures-human-brain-tissue - 2025-02-21

Published 9 January 2020 Madelene Å Andersson, Sven Kjellström, Jitka Petrlova, Artur Schmidtchen, Ann-Charlotte Strömdahl, Manoj Puthia. (Photo: Olle Dahlbäck) Researchers at Lund University in Sweden have developed a new hydrogel based on the body’s natural peptide defense. It has been shown to prevent and treat infections in wounds. The formulation kills multi-resistant bacteria, something that

https://www.medicine.lu.se/article/next-generation-wound-gel-treats-and-prevents-infections - 2025-02-21

By tove [dot] gilvad [at] med [dot] lu [dot] se (Tove Gilvad) - published 23 January 2020 European complementologists have joined forces and created CORVOS. A highly coordinated and innovative research and training program for early stage researchers in immunology and infectious diseases. Lund University is a part of the initiative. Anna Blom, Professor at Lund University, participating in the COR

https://www.medicine.lu.se/article/corvos-european-joint-doctorate-programme-immunology - 2025-02-21

Published 29 January 2020 Immunofluorescence analysis of a melanoma tumor showing that B cells in B cell clusters express CXCR5, a marker for tertiary lymphoid structures. (Source: Göran Jönsson) Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The

https://www.medicine.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2025-02-21

Published 3 February 2020 In a major study of hereditary breast cancer, a global network of researchers (including some from Lund University) has identified over 350 faults in DNA that increase an individual’s risk of developing the disease. The researchers believe that these faults can affect as many as 190 genes. Published in Nature Genetics, a scientific journal, the results are said to be the

https://www.medicine.lu.se/article/major-study-gives-most-comprehensive-map-breast-cancer-risk - 2025-02-21

Published 4 February 2020 Up to 45 per cent of all deaths in industrialised countries are caused by fibrotic diseases. Through boundary-crossing research and the high-tech MAX IV laboratory in Lund it is possible to increase the knowledge of fibrosis – bringing a cure closer. ”Fibrosis is a form of scarring that can affect all types of damaged organs and tissues in the body. When this process take

https://www.medicine.lu.se/article/high-tech-collaboration-supports-fibrosis-research - 2025-02-21

Published 6 February 2020 Within the framework of an international study, Lund University and Skåne University Hospital have started treating patients with hemophilia with gene therapy, something that began in January this year. The hope is that the new treatment will significantly simplify everyday life for those with severe hemophilia. Hemophilia is a genetic disease where the body does not prod

https://www.medicine.lu.se/article/hemophilia-being-treated-gene-therapy - 2025-02-21

Published 6 February 2020 The Leif C. Groop Award for Outstanding Diabetes Research has been awarded to Niels Grarup of the Novo Nordisk Foundation Centre for Basic Metabolic Research at the University of Copenhagen. His research has shown that there is a genetic explanation for the increase in type 2 diabetes in Greenland. The prize, worth SEK 100 000, is donated by the pharmaceutical company Nov

https://www.medicine.lu.se/article/award-research-increased-risk-type-2-diabetes-greenland - 2025-02-21

Published 6 February 2020 In their quest to find new and better methods to make cancer cells more susceptible to treatment, Karin Lindkvist and her research group at Lund University in Sweden are looking into the world of molecules, using the X-rays at the MAX IV laboratory. The researchers believe that limiting the cells' access to sugar will make cancer cells more sensitive to treatment. Many of

https://www.medicine.lu.se/article/researchers-believe-sugar-and-obesity-can-make-cancer-cells-more-difficult-kill - 2025-02-21

Published 19 February 2020 Esther González-Padilla. The more sugar we eat, the less vitamins and minerals we consume, new findings from Lund University in Sweden show. However, the researchers behind the study do not believe that their results alone are enough to make changes to current dietary recommendations. High sugar intake has been associated with numerous diseases and conditions such as poo

https://www.medicine.lu.se/article/more-sugar-less-vitamins-we-eat-study-shows - 2025-02-21

Published 19 February 2020 Martin Magnusson (Photo: Kennet Ruona) A new epidemiological study from Lund University and Skåne University Hospital in Sweden shows that there is a connection between high levels of the gastrointestinal hormone GIP in the blood, and an elevated risk of cardiovascular disease. It is well known that the intestinal hormones GIP and GLP-1 are important for insulin producti

https://www.medicine.lu.se/article/gut-hormone-can-increase-risk-cardiovascular-disease - 2025-02-21

Published 26 February 2020 Diabetes, cardiovascular disease, Parkinson's and Alzheimer's disease make up the world’s most common diseases. A new biobank at Lund University in Sweden - the largest of its kind - with stem cells from both those affected and healthy individuals, will contribute to an increased understanding of how these diseases arise. “The goal is for researchers to be able to develo

https://www.medicine.lu.se/article/worlds-largest-stem-cell-biobank-launched - 2025-02-21